Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
June 6, 2022
UC San Diego researchers report that the causes and death rates of liver cancer are changing around the world.
Your search for “hepatology” returned 42 results
Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth
March 13, 2019
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
UC San Diego Health Named Center of Excellence for Polycystic Kidney Disease
December 13, 2022
UC San Diego Health has been named a Center of Excellence for polycystic kidney disease (PKD) by the PKD Foundation – the leading advocacy group dedicated to finding treatments and a cure for PKD. UC San Diego Health is one of just 28 institutions nationwide to receive this designation.
Caspase-2 Enzyme Inhibition Shows Promise for Ameliorating Fatty Liver Disease
September 13, 2018
Researchers at University of California San Diego School of Medicine have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition. By identifying caspase-2’s critical role, they believe an inhibitor of this enzyme could…
Diabetes Drug Found No Better Than Placebo at Treating NAFLD
May 12, 2016
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by…
Too Much of a Good Thing May Lead to Too Much of a Liver As Well
February 24, 2020
UC San Diego researchers suggest that prolonged exposure to a pair of antioxidant proteins may contribute to enlargement of the liver and fatty liver diseases.
Altman Clinical and Translational Research Building Makes Its Debut
March 10, 2016
…the departments of gastroenterology, hepatology and ophthalmology. “This is a 21st century lab,” said Dr. David Brenner, Vice Chancellor of Health Sciences and Dean of the UC San Diego School of Medicine. Last week’s opening proved particularly poignant to San Diego County Supervisor Ron Roberts, who recalled many years earlier…
Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease
June 16, 2020
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
New Genetic Associations in Pediatric NAFLD Affect Both Risk and Severity
June 27, 2022
In a pair of studies, UC San Diego School scientists have deepened investigations into the genetic origins of nonalcoholic fatty liver disease in children, describing multiple gene variants that contribute to disease risk.
UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center
February 8, 2016
Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego…
